TheEdgeResearch
Home / Stocks / CAMP

CAMP4 Therapeutics Corporation (CAMP)

NASDAQ Healthcare Biotechnology
$4.13 ▼ -0.24%
Market Cap
$87.7M
Sector
Healthcare
Industry
Biotechnology
Beta
0.08
52-Wk Range
1.305-7.75
CEO
Joshua Mandel-Brehm
Country
US
Currency
USD

CAMP4 Therapeutics Corporation, a biotechnology firm, was established in 2015 by Richard A. Young and Leonard Zon. Based in Cambridge, Massachusetts, its core focus is the identification and development of new therapeutic solutions for patients.

Open full interactive analysis & DCF →